NCT01387308 - Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Healthy

Interventions

DRUG

Fostamatinib

Oral tablets, 50 mg x 2, single dose

DRUG

Fostamatinib

Oral tablets, 50 mg x 3, single dose

DRUG

Fostamatinib

Oral tablets, 100 mg, single dose

DRUG

Fostamatinib

Oral tablets, 150 mg, single dose

DRUG

Fostamatinib

Oral tablets, 50 mg x 2, single dose

Trial Locations (1)

Research Site, Overland Park